Mohamad, A. F. (2024) “RISK OF KETOACIDOSIS WITH LUSEOGLIFLOZIN IN TYPE 2 DIABETES MELLITUS PATIENTS ON MODERATE DOSE INSULIN THERAPY: A RANDOMISED CONTROL TRIAL”, Journal of the ASEAN Federation of Endocrine Societies, 39(S1), pp. 34–35. Available at: https://asean-endocrinejournal.org/index.php/JAFES/article/view/4489 (Accessed: 1 October 2024).